doctordave

Liking the Risk/Reward in Generex

If MNKD's Afresa is approved with a clean label then GNBT will be too late at the gate, IMO.

Mannkind: Overlooked Biotech With Excellent Prospects (Part VI)

Written from the advantage of 15 months later than your comments, how does it feel to be proven totally incorrect?


On 2008 Jun 22 11:48 AM Mr BSG wrote:

> " Therefore, the failure of these other three products in the marketplace
> is totally irrelevant."
>
> " why has Mannkind’s stock fallen to $2.89? That’s down a whopping
> 87% from its March 2006 price of $22! "
>
>
> The only thing that's irrelvant is your senseless pumping of this
> stock. You contradict yourself throughout the 6 Part Pump, to the
> point of being totally laughable.
>
> MNKD, PFE, NOVO and Lilly are all inhaled and all have or will (seekingalpha.com/symbo...)
> FAIL.
>
> PFE has the largest Pharma Salesforce in the world and they couldn't
> convince Dr.s or patients to use exubera.
>
> MNKD has no salesforce
>
> MNKD has no partner and will never find a partner to kick in $1 Billion.
>
>
> MNKD has an inferior product that has already been rejected by the
> market.
>
> MNKD will NEVER get FDA Approval.
>
> MNKD will be out of cash by Nov. 2008
>
> MNKD has 600 employees that do exactly WHAT all day!
>
> I stick by my prediction of $1.00 by Dec 2008 and bankrupt in 2009.
> In fact, both may come sooner than expected.
>
> Buyer beware of this dog, regardless of what you read on the internet.
>
>
>

Is It Time to Buy? What History Shows

You're right on bro'. WB said that he was buying, He also said this wasn't necessarily the bottom. Trying to pick the bottom is a fools game, and it can't be done. Prices were low enough to buy, and so he went into the market 100%.

Buy value stocks and hold them long term i.e. 3-5 years and you'll make out like a bandit.


On Dec 09 11:26 AM juan77 wrote:

> The time to buy was when Warren Bufett said it's time to buy. Even
> as so called analysts were procrastinating, the market has quietly
> gone up and stocks aren't the screaming bargains they were a few
> weeks ago. I am not saying that the market will go down, but even
> if it goes up, it's not going to go much higher either.
> For once, I would like to see atleast one analyst telling people
> to buy when there's blood on the streets. Telling people to sell
> when stocks are already down and then telling them to buy when stock
> prices go up is not great advice.

If We Sell on Good News, When Do We Buy?

Ceragon appears to be a well-managed company with an emphasis on a technology that may be the key backbone for the future growth of telecommunications.